Open-Label, Randomised, Controlled Study to Compare the Efficacy and Safety of Cefepime/Sulbactam and Cefepime in Patients With Acute Pyelonephritis

Clinical pharmacology and therapy
doi 10.32756/0869-5490-2018-5-41-45
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmapress LLC

Related search

Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-Analysis

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2018English

An Open Label Study to Evaluate Safety and Efficacy of Unex® Capsules in Patients With Urinary Disorders

Journal of Ayurveda Medical Sciences
2018English

A Baseline-Controlled, Open-Label, Flexible Dose-Escalation Study to Assess the Safety and Efficacy of Sildenafil Citrate (Viagra®) in Patients With Erectile Dysfunction

International Journal of Impotence Research
Urology
2003English

Susceptibilities of Chryseobacterium Indologenes and Chryseobacterium Meningosepticum to Cefepime and Cefpirome.

Journal of Clinical Microbiology
Microbiology
1997English

Cefepime Induced Acute Interstitial Nephritis – A Case Report

BMC Nephrology
Nephrology
2015English

A Controlled, Randomized, Open Label Study in Postmenopausal Women to Assess the Safety and the Efficacy of a Vaginal Moisturizer: An Instrumental Approach

Open Journal of Obstetrics and Gynecology
2013English

Safety and Efficacy of Guselkumab in Japanese Patients With Moderate-To-Severe Plaque Psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study

British Journal of Dermatology
DermatologyMedicine
2018English

Oral Prednisolone for Acute Otitis Media in Children: Protocol of a Pilot Randomised, Open-Label, Controlled Study (OPAL Study)

Pilot and Feasibility Studies
Medicine
2018English

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy